JUMBO GLASS IONOMER CEMENT

{0}------------------------------------------------ Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 3 0 1998 Mr. John Discko ·Executive Vice president Centrix Incorporated 770 River Road Shelton, Connecticut 06484-5458 Re : K980568 Jumbo Glass Ionomer Cement Trade Name: Requlatory Class: II Product Code: EMA February 3, 1998 Dated: Received: February 9, 1998 Dear Mr. Discko: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device; subject to the general controls provisions The general controls provisions of the Act of the Act. include reguirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially_equivalent_determination_assumes_compliance_with ____ the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of {1}------------------------------------------------ Page 2 - Mr. Discko the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours Timothy A. Ulatowski Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ K935436 K980568 510(k) NUMBER (IF KNOWN): om Glass I Onomer Coment. DEV INDICATIONS FOR USE: And 624de For cementing CR ENDOdontic posts, OR orthodoutics Ensociation ports, and be used as A. Filling or core buildup material, filling or correst, first (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGENT S CONTINED ) IF NEEDED.) | Concurrence of CDRH, Office of Device Evaluation (ODE) | | |--------------------------------------------------------|--------------------------------------------------------------------| | | <i>S. SHANKUM</i><br>(Division Sign-Off) | | | Division of Denvi, Infection Control, | | | and General Hospital Devices | | 510(k) Number | K980565 | | Prescription Use | <div style="display:inline-block;">✓</div> OR Over-The-Counter-Use | | (Per 21 CFR 801.109) | (Optional Format 1-2-96) |